New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.

U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says ...

The Washington Examiner prides itself on its in-depth, enterprise, and investigative reporting. Here is a summary of our weekly series in 2024.

Theratechnologies said Thursday that patients will encounter a shortage of Egrifta SV--its prescription medicine that reduces excess belly fat in adults with HIV and lipodystrophy--in mid-January. The ...

AI can compare thousands of images to uncover dangerous patterns, create ultra-high resolution scans from low-res images and ...

Recalls can be issued for a variety of reasons, from undeclared allergens to plastic and bacterial contamination.

Manufacturers increasingly but still infrequently follow Food and Drug Administration guidance that recommends testing pulse oximeters on participants with a range of skin pigmentations, according to ...

Qiagen has received clearance from U.S. regulators to market its gastrointestinal-illness test.

The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...